It's important to note that these are doses observed in preclinical studies or reported within less formal research communities, not FDA-approved human dosages
This is one of the most frequent billing errors for tirzepatide, especially in practices that are new to buy-and-bill for injectable medications
Patients on insulin or sulfonylureas should always carry fast-acting carbohydrate with them
For instance, if youre transitioning from a lower dose of injectable semaglutide, your provider might start you on Rybelsus 7 mg daily, then adjust as needed
PMID 37952131, DOI 10.1056/NEJMoa2307563, SELECT
However, I would also inform them that the incidence of this side effect is relatively low. Wegovy, for instance, was approved for weight loss by the FDA and has already been found to treat type 2 diabetes effectively